Comprehensive Review of Post–organ Transplant Hematologic Cancers

Practice Gap

Many transplant professionals do not currently understand risk factors that may necessitate screening
and prevention strategies for post-transplant hematologic cancers (PTLDs).

Learner Objectives
1. Describe the magnitude of increased risks for various hematologic cancers after organ
2. Understand the known relationships between viral infection, immune surveillance and
immunosuppression as mechanisms of cancer pathogenesis
3. List the prevention and treatment strategies that have been explored for PTLDs

The American Society of Transplant Surgeons (ASTS) is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTS designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Activity Disclosures
Vikas Dharnidharka, MD is a consultant for Bristol-Myers Squibb and Atara Biotherapeutics.

Instructions for completing ASTS MOC – Education through AJT modules
*Please note, you must hit the “next” button at the bottom left after each step to continue in the
1. Review article.
2. Complete post-test. A passing score of 75% is required to move forward. The test can be retaken
as many times as necessary.
3. Complete the evaluation.
4. Access your AJT MOC certificate(s) and transcript of modules completed under the “My
Learning” tab. 


Agree to Acknowledgement to continue.
Agree to Acknowledgement to continue.
Open to download resource.
Open to download resource.
4 Questions  |  3 attempts  |  3/4 points to pass
4 Questions  |  3 attempts  |  3/4 points to pass
10 Questions
10 Questions We value your opinion. Please take a moment to provide your feedback.
1.00 AMA PRA Category 1 credit  |  Certificate available
1.00 AMA PRA Category 1 credit  |  Certificate available